Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | JAK2 |
| Upstream (Parents) |
|---|
| (<<) CCND2 → JAK2 |
| (<<) CREB3 → JAK2 |
| (<<) CSTB → JAK2 |
| (<<) FOXA2 → JAK2 |
| (<<) FZD7 → JAK2 |
| (<<) IL1B → JAK2 |
| (<<) RAC2 → JAK2 |
| (<<) VIM → JAK2 |
| Downstream (Children) |
|---|
| JAK2 → ADCY7 (>>) |
| JAK2 → IL1A (>>) |
| JAK2 → IL6 (>>) |
| JAK2 → ITGB7 (>>) |
| JAK2 → MAP3K8 (>>) |
| JAK2 → MREG (>>) |
| JAK2 → MTRR (>>) |
| JAK2 → MUC2 (>>) |
| JAK2 → PTGS1 (>>) |
| JAK2 → SPRR1B (>>) |
| JAK2 → STAT5A (>>) |
| JAK2 → ZNF365 (>>) |
